Treatment · Editorial team

Spravato (Esketamine) for Treatment-Resistant Depression

Most people do not go looking for a drug name. They go looking because the fog will not lift, the SSRIs did not work, and they are tired of being told to be patient. If that is where you are, Spravato is one of the newer, doctor-supervised options worth understanding. Here is a straight, no-hype explanation.

Spravato is the brand name for esketamine, a nasal-spray medication that the U.S. Food and Drug Administration approved for treatment-resistant depression. Treatment-resistant depression is not a rare or exotic diagnosis. It simply means depression that has not responded to at least two adequate trials of standard antidepressants. That describes a large share of people who live with depression, and many of them also carry PTSD, since trauma and depression frequently travel together.

How it is different from a regular antidepressant

Standard antidepressants such as SSRIs work slowly and act mainly on serotonin. Esketamine works through a different brain pathway, the glutamate system, and for people who respond it can ease symptoms faster than a typical pill. It is not a magic switch and it is not a cure. What the research supports is that, for some people whose depression has not budged, it can meaningfully reduce symptoms when other approaches have fallen short. It is used alongside an oral antidepressant, not usually on its own.

An important distinction. Spravato is FDA-approved for treatment-resistant depression and for depressive symptoms in adults with major depressive disorder who have suicidal thoughts or actions. It is not, on its own, an FDA-approved treatment for PTSD. Because treatment-resistant depression so often rides along with PTSD, some people receive it as part of their overall care, and related ketamine-based treatments are being studied for PTSD symptoms. A qualified clinician decides whether it fits your situation.

Why it has to be given in a clinic

You cannot pick up Spravato at a pharmacy and use it at home. Because of its effects, it is dispensed only through a certified healthcare setting under a federal safety program known as a REMS. You take the nasal spray yourself, but under direct medical supervision, and you stay to be monitored afterward. That structure is a feature, not red tape: it is how the treatment is kept safe.

What a session is actually like

Every clinic runs its own protocol, but the general shape is consistent:

You self-administer the nasal spray in the office while a clinical team observes.
You stay for monitoring for about two hours, because blood pressure can rise and some people feel dissociation, a temporary floaty or detached sensation, or drowsiness.
You do not drive yourself home afterward, so you arrange a ride for the day of treatment.
Early on, sessions are usually twice a week, then taper to weekly and less often as your provider tracks how you respond.

The dissociation and other effects generally fade within the monitoring window. A responsible clinic explains all of this up front, screens you carefully, and does not promise a specific result.

Who it is and is not for

Esketamine is a later-line option, not a first move. It is considered when at least two standard antidepressants have failed to help enough. It is not appropriate for everyone: certain heart and blood-vessel conditions, a history of some kinds of bleeding in the brain, and other factors can rule it out or require caution. Pregnancy and some substance-use histories also matter. This is exactly why the screening step exists. If a clinic is willing to sign you up without a careful history, that is a warning sign, not a convenience.

Does insurance cover it in Missouri?

Spravato is covered by most major insurance plans, including MO HealthNet (Missouri Medicaid), when the medical criteria are met, typically documented treatment-resistant depression. Coverage usually requires prior authorization, meaning the clinic submits records showing that standard treatments were tried first. A good clinic handles that paperwork with you and checks your specific benefits before you start, so you are not surprised by cost. Our guide to TRICARE, VA, and MO HealthNet coverage explains the broader landscape for veterans and military families.

How Spravato fits with everything else

Esketamine is not a replacement for the rest of your care. It works best as one piece of a plan that can also include an oral antidepressant, trauma-focused therapy if PTSD is in the picture, better sleep, and support around you. If you have not yet mapped out the full menu, start with our guide to PTSD treatment options, which covers therapy, medication, TMS, and esketamine side by side. If depression and trauma both apply to you, our guide to PTSD and depression together is written for exactly that overlap.

How to ask about it

The single most useful step is a conversation with a doctor. Your own physician or psychiatrist is usually the key that unlocks treatment, because a referral and documented treatment history are what coverage depends on. You can say it plainly: "Standard antidepressants have not worked for me. Am I a candidate for something like Spravato or TMS?" If your current provider does not offer these treatments, ask for a referral to a clinic that does. People search their symptoms, not drug names, and that is fine. Bring the symptoms; let the clinician bring the options.